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Abstract 
 
Indigenous Australians are disadvantaged, relative to other Australians, over a range of socio-economic and 
health measures. The age- and sex-adjusted incidence of end-stage renal disease (ESRD) – the irreversible 
preterminal phase of chronic renal failure – is almost nine times higher amongst Indigenous than it is amongst 
non-indigenous Australians. A striking gradient exists from urban to remote regions, where the standardised 
ESRD incidence is from 20 to more than 30 times the national incidence. We discuss the profound impact 
of renal disease on Indigenous Australians and their communities. We explore the linkages between 
disadvantage, often accompanied by geographic isolation, and both the initiation of renal disease, and its 
progression to ESRD. Purported explanations for the excess burden of renal disease in indigenous 
populations can be categorised as: 
(1) primary renal disease explanations; 
(2) genetic explanations; 
(3) early development explanations; and 
(4) socio-economic explanations. 
 
We discuss the strengths and weaknesses of these explanations and suggest a new hypothesis which 
integrates the existing evidence. We use this hypothesis to illuminate the pathways between disadvantage 
and the human biological processes which culminate in ESRD, and to propose prevention strategies across 
the life-course of Indigenous Australians to reduce their ESRD risk. 
Our hypothesis is likely to be relevant to an understanding of patterns of renal disease in other high-risk 
populations, particularly indigenous people in the developed world and people in developing countries. 
Furthermore, analogous pathways might be relevant to other chronic diseases, such as diabetes and 
cardiovascular disease. If we are able to confirm the various pathways from disadvantage to human biology, 
we will be better placed to advocate evidence-based interventions, both within and beyond the scope of the 
health-care system, to address the excess burden of renal and other chronic diseases among affected 
populations. 
 
Keywords: Aboriginal health; renal disease; social determinants; biological pathways; 
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Introduction 
On November 11, 2000, Sotheby’s held an auction of Australian Aboriginal artworks at the Art 
Gallery of New South Wales, in Sydney. Thirty-five pieces were auctioned, including canvases 
painted by residents of Kintore and Kiwirrkura, remote Aboriginal communities hundreds of 
kilometres west of Alice Springs in central Australia. The auction was part of the Western Desert 
Dialysis Art Appeal, which raised over one million Australian dollars. Why would two remote 
Aboriginal communities, each with only a few hundred residents, need haemodialysis units? 
Haemodialysis is used to treat end-stage renal disease (ESRD), the irreversible pre-terminal 
phase of chronic renal failure. Someone suffering ESRD will die without treatment. In the 
developed world, treatment for ESRD is generally available, either maintenance dialysis (the 
majority of which is haemodialysis) or renal transplantation. Haemodialysis is an expensive 
Social Science & Medicine (2004) 58 (4): 767–785.   doi:10.1016/S0277-9536(03)00243-0 
 
tertiary care service, usually provided in urban centres only. Almost one in five Indigenous 
Australians (Aborigines and Torres Strait Islanders) live in remote communities like Kintore 
and Kiwirrkura, compared with less than one in 100 of the total Australian population 
(Australian Bureau of Statistics and Australian Institute of Health and Welfare, 2001). 
Indigenous Australians with ESRD in remote communities must leave their community to 
commence dialysis. Very few receive transplants; most remain on haemodialysis, hundreds of 
kilometres from home, in a satellite unit of an urban hospital. The people of Kintore and 
Kiwirrkura have taken drastic action to keep sick members in the community. But why are these 
communities so affected by ESRD in the first place, when fewer than 1 in 10,000 Australians 
start ESRD treatment each year (Russ, 2002)? 
As a group, Indigenous Australians are disadvantaged, relative to other Australians, over a 
range of socio-economic and health measures. In 1996, indigenous adults were less likely to 
have a post-school educational qualification (11% versus 31%), more likely to be unemployed 
(23% versus 9%), and much less likely to own or to be purchasing their home (31% versus 71%) 
(Australian Bureau of Statistics and Australian Institute of Health and Welfare, 1999). The 
median weekly income for indigenous males was $189, compared with $415 for non-indigenous 
males. The disparity between females was not as marked, with median weekly incomes of $190 
and $224, respectively (Australian Bureau of Statistics and Australian Institute of Health and 
Welfare, 1999). 
In 1997–1999, estimated Indigenous Australian life expectancy at birth was 56 years for males, 
compared with 76 for all males, and 63 years for females, compared with 82 for all females 
(Australian Institute of Health and Welfare, 2002). Most of the difference is due to premature 
adult mortality from chronic diseases (Cunningham & Paradies, 2000). There were seven–eight 
times more deaths from genitourinary diseases than expected; most were due to renal failure 
(Cunningham & Paradies, 2000). 
The incidence of ESRD throughout the developed world is markedly higher amongst 
indigenous people (Dyck, 2001; Russ, 2002; US Renal Data System, 2001). In 2000, Indigenous 
Australians constituted less than 2% of the national population, but comprised over 8% of new 
patients commencing treatment for ESRD (Russ, 2002). ESRD is generally a disease of older 
people. However, the Indigenous Australian population, as a whole, is much younger, with a 
median age in 1996 of20 years, compared to 34 years for the total Australian population 
(Australian Institute of Health and Welfare, 2002). After adjusting for age and sex, the ESRD 
incidence rate in 1997 was almost nine times higher for Indigenous Australians (Cass, McDonald, 
& Wang, 1999). 
The burden of ESRD is greater everywhere for Indigenous Australians, but there are striking 
geographical differences in incidence within this population (Fig. 1). A large gradient exists 
from urban to remote regions (Cass, Cunningham, Snelling, Wang, & Hoy, 2002b). In remote 
communities, including places like Kintore and Kiwirrkura, the standardised ESRD incidence is 
from 20 to more than 30 times the national incidence (Cass, Cunningham, Wang, & Hoy, 2001b). 
Can we explain the link between, on the one hand, disadvantage and geographical isolation and 
on the other, the initiation of renal disease and its progression to ESRD? 
The explanations offered for the excess burden of renal disease in Indigenous populations and 
in other minorities, for example, African Americans, can be categorised as: 
 
1. primary renal disease explanations – population differences result from a higher 
incidence, and greater severity, of various primary diseases which cause ESRD; 
2. genetic explanations – genetic differences determine various patterns of ESRD; 
3. early development explanations – some form of adverse intrauterine environment affects 
kidney development, leading to a vulnerability to ESRD and; 
4. socio-economic disadvantage explanation – greater socio-economic disadvantage in 
minority and Indigenous populations results in a higher incidence of ESRD. 
 
In this paper, we review the strengths and weaknesses of each of these explanations and put 
forward a new hypothesis which integrates all the existing evidences. Using this hypothesis, we 
illuminate the pathways between disadvantage and the human biological processes which 
culminate in ESRD, and propose prevention strategies across the life-course of Indigenous 
Australians to reduce their risk of ESRD. 
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Fig. 1. Standardised incidence of ESRD in the Indigenous Australian population by ATSIC region: (*) 
The standardised incidence ratio for the Torres Strait ATSIC region was 15.0. The region is too small 
to represent at this level of map resolution. (†)The index population for standardisation was the total 
Australian resident population. (Cass, A., et al. (2001). Regional variation in the incidence of ESRD in 
Indigenous Australians. Medical Journal of Australia, 175, 24–27. Copyright 2001, reproduced with 
permission.) 
 
Primary renal disease explanations 
 
Nephrologists conceive of the causes of ESRD in terms of primary renal diseases which cause 
kidney tissue damage, resulting eventually in ESRD. In the Australia and New Zealand Dialysis and 
Transplant Registry (ANZDATA), which covers all Australian renal units, cases are assigned to one 
of69 primary renal diseases (Russ 2002). Examples include membranous glomerulonephritis, 
analgesic nephropathy, renal vascular disease due to hypertension, polycystic kidney disease and 
type 2 diabetes. The diagnostic criteria are not mutually exclusive and the boundaries between the 
various disease entities are not clearly defined (Perneger, Brancati, Whelton, & Klag, 1995a). 
However, in order to facilitate discussion of the distribution of causes of ESRD, the 69 primary 
renal diseases may be classified according to eight major diagnostic categories (see Table 1) 
(Russ, 2002). 
Among new ESRD cases in Australia during 1993– 1998, there were different patterns of 
primary renal disease, according to whether or not the patient was indigenous (Table 1). Almost half of 
ESRD cases in Indigenous Australians were attributed to diabetes, compared to approximately one 
in six non-indigenous cases. Glomerulonephritis was attributed as the cause of approximately one 
in four indigenous and one in three non-indigenous patients. An uncertain diagnosis was 
significantly more likely to be recorded in respect of Indigenous Australian patients. Other disease 
categories were less common among the indigenous patients (Table 1). 
High ESRD rates in indigenous populations have been related to the growing epidemic of type 2 
diabetes (Dyck, 2001; Nelson, 2001). Surveys in Australian Aboriginal communities have confirmed a 
very high prevalence of impaired glucose tolerance (IGT) and type 2 diabetes (Daniel, Rowley, 
McDermott, & O’Dea, 2002). Almost 2/3 of indigenous ESRD patients have diabetes at the time of 
commencement of RRT ( Russ, 2002). Attributing the excess burden of ESRD to a higher 
incidence, prevalence and greater severity of diabetes is consistent with both genetic and early 
development explanations. However, the validity of the attribution of ESRD to primary causes, 
such as diabetes, has been questioned (Perneger et al., 1995a). 
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TABLE 1: Attributed primary cause of ESRD for new Australian ESRD patients, 1993–98a 
Cause Indigenous (n = 719) Non-indigenous (n = 7409) P valueb 
Diabetes 322 (44.8%) 1281 (17.3%) < 0.001 
Glomerulonephritis 204 (28.4%) 2535 (34.2%) 0.001
Uncertain 100 (13.9%) 436 (5.9%) < 0.001
Hypertension 35 (4.9%) 837 (11.3%) < 0.001
Miscellaneous 31 (4.3%) 813 (11.0%) < 0.001
Reflux 13 (1.8%) 396 (5.3%) < 0.001
Analgesic use 8 (1.1%) 552 (7.5%) < 0.001
Polycystic kidney disease 6 (0.8%) 559 (7.5%) < 0.001 
aData sourced from ANZDATA Registry, 2001. 
bPearson’s chi-square test was used for comparison of indigenous and non-indigenous patients. 
 
Disparate systems of classification of primary renal diseases in different countries hinder cross-
national comparisons of the frequency of primary renal diseases leading to ESRD (Maisonneuve 
et al., 2000). Because histopathological examination of renal tissue obtained at percutaneous 
biopsy has been considered the diagnostic gold standard, it could be argued that increased use of 
renal biopsy might improve the accuracy of diagnosis of the causes of ESRD. However, few 
biopsies are performed in indigenous ESRD patients and there is evidence that even the 
interpretation of histological findings is affected by the nephrologist’s knowledge of the patient’s 
‘race’ (Perneger et al., 1995a). 
Since 1998, ANZDATA has collected data recording whether or not new ESRD patients have a 
diagnostic renal biopsy. During 1998–2000, 37% of 5115 new ESRD patients had a diagnosis 
based on renal biopsy (ANZDATA, special data request, 2002). Fewer indigenous patients 
underwent biopsy (27% versus 38%, p < 0 :001). This can be explained, at least in part, by a 
greater proportion of indigenous ESRD patients presenting late in the course of their disease and 
by their much greater prevalence of diabetes. 
A study of the consequences of late referral for specialist care showed that almost 40% of 
Indigenous ESRD patients needed to commence dialysis within three months of referral to a 
nephrologist (i.e. they were referred late) (Cass et al., 2002a). For patients near to needing 
dialysis, not only is the risk of significant complications with renal biopsy much greater (Stiles et 
al., 2000), but biopsy specimens are often uninformative, showing only non-specific evidence of 
scarring and atrophy (Perneger et al., 1995a). Thus, in almost 40% of indigenous ESRD patients, 
the performance of a renal biopsy to help establish a diagnosis is associated with enhanced risk of 
complications and poor diagnostic yield. Indigenous patients referred late were three times more 
likely to have an uncertain diagnosis than those not referred late (Further analysis of data from 
Cass et al., 2002a). Patients whose ESRD was attributed to diabetes were less likely to have 
undergone biopsy (ANZDATA, special data request, 2002). Among the 45% of indigenous cases 
attributed to diabetes, only 17% had a confirmatory biopsy. 
In a US study, nephrologists were sent written case histories based on the presentation of seven 
ESRD patients. Race was randomly allocated as ‘black’ or ‘white’. When the race was specified as 
‘black’ rather than ‘white’, the same case history of renal failure was almost twice as likely to be 
diagnosed as ESRD due to hypertension (Perneger, Whelton, Klag, & Rossiter, 1995c). Similarly, 
Indigenous Australian ESRD patients, who are more likely than non-indigenous patients to have 
diabetes at the time of commencement of treatment (66% versus 24%, p o 0 :001), may be more 
likely to have their ESRD attributed to diabetes, whether it is the fundamental cause of renal 
damage or, is instead, a concurrent and contributory illness. Although intuitively appealing, the 
primary renal disease explanations add little to our understanding of Indigenous Australians’ 
higher burden of ESRD. In practice, they offer an imperfect taxonomy rather than an explanation. 
 
Genetic explanations 
 
Many researchers propose that both the initiation of renal disease and its progression to ESRD are 
genetically determined (Iyengar, Schelling, & Sedor, 2002). Research examining the high ESRD 
incidence in ethnic minorities, including indigenous minorities, has focused on ‘racial’ 
differences in physiological processes and pathological responses (Freedman, 2002). These re-
sponses have been attributed to genetic factors (Freed-man, 2002; Iyengar et al., 2002; Parmer, 
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Stone, & Cervenka, 1994). 
There is substantial evidence that ESRD clusters in families (Fogarty, Rich, Hanna, Warram, & 
Krolewski, 2000; Freedman, Bowden, Rich, & Appel, 1998; Schelling, Zarif, Sehgal, Iyengar, & 
Sedor, 1999). This familial aggregation occurs in excess of that predicted by the clustering of risk 
factors, including the presence and severity of diabetes and hypertension (Lei, Perneger, Klag, 
Whelton, & Coresh, 1998). Familial clustering of diabetic and non-diabetic renal disease has been 
reported among Pima (Pettitt, Saad, Bennett, Nelson, & Knowler, 1990) and Zuni American 
Indians (Hoy, Megill, & Hughson, 1987). Familial clustering of proteinuria, a marker of renal 
disease, has also been demonstrated in a number of Indigenous Australian communities (Hoy et 
al., 1998; Van Buynder, Gaggin, & Mathews, 1993). However, familial clustering might reflect 
shared exposure to adverse socio-economic or environmental factors, rather than a genetic predis-
position. 
We have already discussed the attribution of high ESRD rates among indigenous populations to 
the growing epidemic of type 2 diabetes (Dyck, 2001; Nelson, 2001). The ‘thrifty genotype’ 
hypothesis suggests a possible explanation for the epidemic of type 2 diabetes in indigenous 
populations, as they make the rapid transition from traditional lifestyles to western diets and 
lifestyles (Neel, 1962). Neel postulated that the ‘feast and famine’ conditions which prevailed 
through-out most of human history might have selected for a ‘thrifty’ metabolism, facilitating 
efficient fat storage in times of food abundance and providing an energy buffer in times of scarcity 
(Neel, 1962). Using this hypothesis, the steep gradient in incidence of ESRD from urban to remote 
regions among Indigenous Australians (Cass et al., 2002b) could be explained by ‘genetic 
admixture’: urban Indigenous Australians might be protected to some degree from type 2 diabetes, 
and therefore from ESRD, through several generations of non-indigenous admixture (Williams, 
Moffitt, Fisher, & Bashir, 1987). 
The ‘thrifty genotype’ hypothesis has subsequently been questioned, not least by its original 
proponent. Neel recently suggested that his early hypothesis had presented an overly simplistic 
view of the physiological adjustments involved in the transition from a hunter-gatherer lifestyle to 
a western lifestyle (Neel, 1999). He reviewed evidence relating to the high incidence of type 2 
diabetes among American Indians and concluded that it must predominantly reflect environmental 
changes rather than a ‘racial’ or genetic predisposition (Neel, 1999). Similarly, the rapidity of the 
increase in ESRD incidence among Indigenous Australians over the last 25 years (Spencer, Silva, 
Snelling, & Hoy, 1998) is not compatible with a genetic explanation. 
Nevertheless, as with other chronic diseases, genes are not irrelevant, and differences in 
susceptibility, possibly attributable to genetic differences, are of interest. Genetic studies have 
reported possible locations of ‘renal failure susceptibility genes’ in indigenous populations 
(Nelson, 2001). Two strategies have been widely used in searches for genetic linkage (Freedman 
et al., 1998). The first, a ‘candidate gene’ approach, analyses the relationship between the disease 
of interest and the presence of a polymorphic DNA marker within or near a possible causative 
gene. One limitation with this approach is that it is constrained to testing for known genes. 
In nephrology, this line of research has focused predominantly on genes coding for the renin–
angiotensin system, which plays a central role in blood pressure regulation (Nelson, 2001). It has 
been postulated that, in Caucasians, the DD genotype of the angiotensin-I-converting enzyme 
(ACE) gene is an independent risk factor for renal disease (Dudley, Keavney, Stratton, Turner, & 
Ratcliffe, 1995), associated with an increased rate of progression of kidney damage in diabetes 
(Parving et al., 1996; Yoshida et al., 1996) and IgA glomerulonephritis (Harden et al., 1995). 
However, others have failed to replicate these associations (Schena, D’Altri, Cerullo, Manno, & 
Gesualdo, 2001; Schmidt, Schone, & Ritz, 1995). The DD genotype of the ACE gene occurs 
infrequently in Indigenous Australians (Lester et al., 1999), in whom no significant influence on 
renal disease has been demonstrated. A recent study in a remote Indigenous Australian community 
has, however, found an association between a common polymorphism of the p53 gene and 
proteinuria (McDonald et al., 2002). 
The second approach to genetic linkage studies, involving a genome-wide search, has the 
potential to locate previously unknown genes which might contribute to disease. In this strategy, 
hundreds of highly polymorphic microsatellite markers, which provide complete coverage of the 
human genome, are tested for coinheritance with a disease (Freedman et al., 1998). For diseases 
demonstrating late age-at-onset, such as ESRD, affected sibling pairs are commonly used to 
evaluate evidence of genetic linkage (Freedman et al., 1998). This is because few ESRD patients 
will have living parents, and the children of the affected individuals might be too young to 
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demonstrate even early markers of renal disease. 
Imperatore et al. (1998) undertook a genome-wide scan for loci linked to diabetic nephropathy 
among 98 diabetic Pima Indian sib-pairs. They found four chromosomal areas with possible 
linkage to diabetic nephropathy. The strongest evidence for linkage was on chromosome 7. The 
peak LOD score (an indicator of the strength of linkage between the genetic locus and disease 
phenotype under investigation) for the area on chromosome 7 did not reach the threshold for 
statistical significance in a genome-wide scan (Imperatore et al., 1998). The evidence for linkage 
for three other regions on chromosomes 3, 9 and 20 was suggestive, but again not statistically 
significant (Imperatore et al., 1998). Among Indigenous Australians, a genome-wide scan for 
susceptibility to type 2 diabetes reported linkage to an area on chromosome 2 (Busfield et al., 
2002), but this methodology has not been used to examine renal disease susceptibility in 
Indigenous Australians. 
Explanatory models for disease which give primacy to genetic determinants focus almost 
exclusively on individual biological and behavioural correlates of illness (Baird, 2000). However, 
in disorders of multi-factorial origin, including ESRD, where environmental and socio-economic 
factors influence health status, gene/gene and gene/environment interactions are complex (Baird, 
1994). Much of the genetic research has been based on ‘racial difference’, a concept which lacks a 
firm scientific foundation (Williams, 1997). The American Association of Physical Anthropology 
has concluded, ‘pure races in the sense of genetically homogeneous populations do not exist in the 
human species today’ (American Association of Physical Anthropology, 1996). By contrast with 
the considerable biological variation within human populations, the biological differences 
between population groups are small. These differences reflect both inheritance and the influence 
of the natural and social environment, with most differences being attributed to their interaction 
(Williams, 1997). Genetic approaches to understanding Indigenous ESRD tend to ignore a large 
and growing body of literature emphasising the primacy of social, cultural and environmental 
factors in determining patterns of disease in particular populations (Baird, 2000). 
 
Early development explanations 
 
Early development provides good examples of the nexus between genes and the environment, and 
of the difficulty in separating them. There has been much interest recently in the relationship 
between fetal and/or infant growth and nutrition and adult chronic disease (Barker & Osmond, 
1986; Barker & Osmond, 1987a; Barker & Osmond, 1987b). Fetal malnutrition, marked by low 
birth weight (LBW), has been linked with a predisposition to hypertension, type 2 diabetes, 
dyslipidaemia and cardiovascular disease (Barker et al., 1993; Barker & Martyn, 1992; Hales & 
Barker, 1992). Among Pima Indians, evidence suggests an intergenerational effect of maternal 
diabetes consistent with the ‘fuel-mediated teratogenesis’ hypothesis (Freinkel, 1980). High rates 
of obesity (Pettitt, Baird, Aleck, Bennett, & Knowler, 1983) and early onset of type 2 2 diabetes 
(Pettitt et al., 1988) have been demonstrated among the offspring of Pima mothers who had 
diabetes during pregnancy. In this review however, we focus on the proposed linkage of 
intrauterine malnutrition with the progression of renal injury (Brenner & Chertow, 1994) and a 
predisposition to ESRD among Indigenous Australians (Hoy, Rees, Kile, Mathews, & Wang, 
1999). The uterine environment might be directly relevant to ESRD through its influence on 
kidney development during intrauterine life. 
Nephrons, the functional units of the kidney, begin to form around week 8 of gestation (Merlet-
Benichou, Vilar, Lelievre-Pegorier, Moreau, & Gilbert, 1997), but the majority form in the third 
trimester (Hinchliffe, Sargent, Howard, Chan, & van Velzen, 1991). None develop after birth 
(Hinchliffe, Lynch, Sargent, Howard, & Van Velzen, 1992; Merlet-Benichou et al., 1997). The number 
in a whole kidney can be reliably estimated using direct stereological counting (Bertram, 2001). 
Evidence from autopsy studies suggests a wide range in the number of nephrons in the ‘normal’ kidney 
(Hoy et al., 2003; Nyengaard & Bendtsen, 1992). Nephrons are lost both with ageing (Moore, 1931; 
Nyengaard & Bendtsen, 1992; Tauchi, Tsuboi, & Okutomi, 1971) and due to a variety of nephropathic 
insults. Damage to the glomerulus, the filtration segment of the nephron, is marked by protein leakage 
into the urine, making the appearance of urinary protein or albumin a marker of early renal 
disease. 
Although the number of nephrons is fixed at birth, glomerular size can increase in response to a 
deficit in numbers (Merlet-Benichou et al., 1997), with a resulting restoration of total filtration 
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surface and excretory homeostasis. However, this adaptation might come at a high price. The 
excessive glomerular enlargement might accelerate the loss of nephrons through glomerular 
hypertension and hyperfiltration injury (Brenner, Lawler, & Mackenzie, 1996). Increased 
glomerular capillary pressure has been postulated as a key mediator of progressive scarring 
(sclerosis) (Fogo, 2000). This scarring induces a self-perpetuating cycle of nephron loss, leading 
to further enlargement, increased flow and pressure in the remaining glomeruli, leading to further 
sclerosis and nephron loss. This process might culminate in ESRD when there are insufficient 
nephrons to sustain life. It seems plausible that people born with fewer nephrons might be 
predisposed to develop hypertension, progressive renal insufficiency and ESRD (Brenner & 
Chertow, 1994; Brenner, Garcia, & Anderson, 1988). They might, in effect, have less renal 
reserve to lose. 
Intrauterine (Hinchliffe et al., 1992; Merlet-Benichou et al., 1997) and/or genetic influences 
(Lipschutz, 1998; Rauchman, 2000) might determine nephron number. Intrauterine growth retardation 
(IUGR), usually defined as being within the lightest 10% of birth weights in a standard population in 
each gestational age stratum, is not a specific disease entity per se, but rather a manifestation of 
various fetal and maternal disorders (Resnik, 2002). Among Indigenous Australians, maternal 
malnutrition, smoking and teenage pregnancy have been established as important causes of IUGR 
((Sayers & Powers, 1997). In a 1987–1991 study in a large hospital, 114 (22.7%) of 502 
Indigenous Australian babies were recorded as having IUGR (Sayers & Powers, 1993). In 1994–
1996, LBW (also a marker of fetal malnutrition) occurred in 12.4% of indigenous births 
compared with 6.2% of non-indigenous births (Day, Sullivan, & Lancaster, 1999). 
Merlet-Benichou and colleagues, using rat models of kidney development, have suggested that 
the fetal environment plays a determining role in kidney development (Lelievre-Pegorier & 
Merlet-Benichou, 2000). Research has suggested that maternal malnutrition (Zeman, 1968), 
maternal hyperglycemia (Amri, Freund, Vilar, Merlet-Benichou, & Lelievre-Pegorier, 1999), drug 
exposure (Nathanson, Moreau, Merlet-Benichou, & Gilbert, 2000) and vitamin A deficiency 
(Lelievre-Pegorier et al., 1998) impair kidney development and result in reduced nephron number 
in the offspring. In animal models, IUGR produced by partial uterine artery ligation leads to a 
permanent nephron deficit (Merlet-Benichou, Gilbert, Muffat-Joly, Lelievre-Pegorier, & Leroy, 
1994). However, the relevance of such animal models to human renal development has been 
questioned (Jones, Nyengaard, Flyvbjerg, Bilous, & Marshall, 2001). 
A small number of histological studies in humans have explored the association between 
nephron number and IUGR or birth weight. A retrospective study of 35 neonatal deaths 
(Manalich, Reyes, Herrera, Melendi, & Fundora, 2000) showed a strong correlation between 
glomerular number and birth weight (r = 0:87; p <0.0001). IUGR was associated with a significant 
reduction in nephron number in a prospective study of 32 stillbirths and infant deaths (Hinchliffe 
et al., 1992). In a study of 24 full-term infants who died in utero or within 6 months of birth, 
nephron number was reduced by 30% in those with IUGR (Merlet-Benichou, Leroy, & Gilbert, 
1993). A current autopsy study is examining the relationship between nephron number, size and 
birth weight in Australian Aborigines, African Americans and Caucasians (Bertram, Johnson, 
Hughson, & Hoy, 2001). A preliminary report indicates that children and adults with LBW have, 
on average, 37% fewer nephrons than those with higher birth weights (Hughson et al., 2003). 
There is also evidence of a relationship between birth weight and clinical or pathological 
evidence of progressive renal disease in indigenous populations. IUGR or LBW has been 
associated with albuminuria (albumin excretion in the urine) in Pima Indians with type 2 diabetes 
(Nelson, Morgenstern, & Bennett, 1998). (In this paper, we use the term albuminuria to indicate 
albumin excretion of more than 300 mg per 24 h.) High rates of albuminuria have been found in 
rural and remote indigenous communities in Australia (Guest, Ratnaike, & Larkins, 1993; Hoy et 
al., 1998; Rowley et al., 2000b). In one prospective cohort study, the level ofalbuminuria at 
screening predicted risk of death and risk of progression to ESRD (Hoy et al., 2001). Birth 
weights were available from clinic records for the majority of the adults screened. After 
adjustment for age, gender, BMI and blood pressure, the odds ratio for albuminuria in LBW 
persons, compared to those with higher birth weights, was 2.82 (95% CI 1.26–6.31) (Hoy et al., 
1999). There is evidence, therefore, among Indigenous Australians, that birth weight is linked to 
albuminuria, which predicts progression to ESRD. 
Published biopsy series from Indigenous Australians with overt renal disease show a wide range 
of morphological diagnoses (Moore, Lloyd, Pugsley, & Seymour, 1996). Pathological changes in 
the glomerulus can usually be characterized by one or more of the following basic tissue reactions 
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(Cotran, Kumar, & Collins, 1999): hypercellularity, basement membrane thickening, hyalinisation 
or sclerosis. However glomerulomegaly, or glomerular enlargement in the absence of 
hypercellularity, is a striking finding in kidney biopsies from Indigenous, but not from non-
indigenous Australians (Bertram, Young, Seymour, Kincaid-Smith, & Hoy, 1998; Moore et al., 
1996; Young, Hoy, Kincaid-Smith, Seymour, & Bertram, 2000). Glomerulomegaly has also been 
demonstrated in African Americans (Abdi, Slakey, Kittur, & Racusen, 1998; Pesce et al., 1994). A 
current autopsy study, which includes Indigenous Australian, African American and Caucasian 
subjects, has demonstrated a significant inverse relationship between glomerular number and 
glomerular size (Bertram et al., 2001; Hoy et al., 2003). These findings are consistent with the 
hypothesis that reduced nephron number at birth might confer an increased susceptibility to renal 
disease and that compensatory enlargement of remaining glomeruli might lead to progressive 
damage through glomerular hyperfiltration and scarring. 
This substantial body of research suggests that nephron endowment at birth, crucially 
influenced by the intrauterine environment, might be causally related to the development of 
ESRD in adult life. However, fetal growth might not be linked causally to chronic disease. There 
might be shared genetic mechanisms for fetal growth and later chronic disease (Wilcox, 2001). 
The validity of the suggested association between fetal development and chronic disease has also 
been questioned on the basis of a perceived failure to define, measure and adequately control for 
confounding due to socio-economic disadvantage (Joseph & Kramer, 1996). 
 
Socio-economic disadvantage explanations 
 
There is strong evidence of a relationship between socio-economic position and overall morbidity 
and mortality (Krieger, Williams, & Moss, 1997). The gradient in the occurrence of disease 
progressively favours those of higher socio-economic status (Marmot, 2000). This has been 
confirmed amongst Australians (Glover, Harris, & Tennant, 1999; National Health Strategy, 
1992; Turrell, Oldenburg, McGuffog, & Dent, 1999). In general, research into Australian health 
inequalities has inadequately controlled for confounding by indigenous status and has failed to 
investigate health gradients within the indigenous population. 
Inconsistent results have been obtained from the few previous studies of the association between 
socio-economic status and the incidence of ESRD (Byrne, Nedelman, & Luke, 1994; Cass, 
Cunningham, Wang, &Hoy, 2001c; Khan, Cheng, Catto, Edward, & MacLeod, 1993; Perneger, 
Whelton, & Klag, 1995b; Young, Mauger, Jiang, Port, & Wolfe, 1994). A study in the Grampian 
region of Scotland (Khan et al., 1993) found no association between socio-economic status and 
the incidence of ESRD. In New York (Byrne et al., 1994), an association was found in White 
Americans, but not in African Americans. In a nationwide US study (Young et al., 1994), a 60% 
higher incidence of ESRD was found in the lowest compared to highest income categories for 
both White and African Americans. In a study of ESRD incidence in Australian capital cities, we 
found a significant association between the incidence of ESRD and a regional-level index of 
disadvantage (Cass et al., 2001c), with up to three-fold variation in incidence. An individual level, 
population-based, case-control study of patients starting ESRD treatment in four East Coast states 
in the US (Perneger et al., 1995b) found that the adjusted risk for development of ESRD was 4.5 
times higher in the lowest compared to the highest income category, with White and African 
Americans demonstrating a similar gradient. 
Only one study of social disadvantage and ESRD in Indigenous Australians has been reported to 
date (Cass et al., 2002b). In this ecological study, strong associations were evident between age- 
and sex-standardised, area-level, ESRD incidence (based on ANZDATA Registry information) 
and area-level markers of social disadvantage (Table 2). The correlation with the overall rank of 
socio-economic disadvantage was particularly strong (Table 2 and Fig. 2). Although it has been 
argued that area-level measures of social disadvantage are poor surrogates for individual-level 
characteristics (Robinson, 1950), it is becoming increasingly accepted that community-level 
exposures to features of the social and physical environment in which people live might directly 
affect health outcomes (Macintyre & Ellaway, 2000). For example, in many disadvantaged 
indigenous communities there is poor access to preventive health services and to stores selling 
healthy foods at reasonable prices, as well as a lack of community infrastructure for basic water, 
sewerage and housing needs (Bailie et al., 2002). 
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TABLE 2. Correlation between indicators of socioeconomic disadvantage and age and sex-
standardised incidence of ESRD for Indigenous Australians for the 36 ATSIC regionsa 
 
Socioeconomic indicator (units) Range Correlation coefficient P 
lEarly school leaversb (%) 12.5–52.4 0.68 <0.001
Unemployment ratec (%) 20.2–74.8 0.72 <0.001
Household incomed ($AUS) 80–194 –0.71 <0.001
House crowdinge 1.1–3.2 0.84 <0.001
Low birth weightf (%) 7.6–21.6 0.49 0.003
Summary rank of disadvantage g 1–36 0.88 <0.001
 
Cass, A., et al. (2002). ESRD in Indigenous Australians: a disease of disadvantage. Ethnicity and 
Disease, 12(3), 373–378. Copyright 2002, reproduced with permission. 
 
aAboriginal and Torres Strait Islander Commission regions are legally prescribed administrative 
areas and are the smallest geographical areas for which accurate Indigenous Australian population 
estimates are available (Australian Bureau of Statistics, 1999 ).  
bThe proportion of adults who left school aged 15 or less, or who did not attend school (Australian 
Bureau of Statistics, 2002 ).  
cPeople employed through the Community Development Employment Projects scheme, a ‘work 
for the dole’ scheme targeted at indigenous communities, were classified as unemployed 
(Australian Bureau of Statistics, 2002 ). 
dMedian household income divided by the average number of persons per household – units are 
$AUS per household member per week (Australian Bureau of Statistics, 1998 ). 
eThe average number ofpersons per bedroom ( Australian Bureau of Statistics, 2002 ). 
fThe proportion ofbirths less than 2500 0g g ( (Day, Sullivan, & Lancaster, 1999). 
gWe combined the regional rankings on each indicator, with each indicator given equal weight, to 
derive a summary rank of disadvantage. 
 
 
Fig. 2. Socio-economic disadvantage and indigenous ESRD incidence by ATSIC region, Australia 
1993–98. (Cass, A., et al. (2002). The relationship between the incidence of ESRD and markers of 
socio-economic disadvantage. New South Wales Public Health Bulletin, 13(7), 147–151. Copyright 
2002, reproduced with permission.) 
 
A novel explanation of Indigenous ESRD 
 
How might disadvantage lead to ESRD? What pathways or mechanisms lead to the biological 
expression of Indigenous Australians’ experiences of economic and social disadvantage, thereby 
producing the steep social gradient in the incidence of ESRD? How can we integrate our 
understanding of the suggested pathophysiological pathways to ESRD with what we know about 
the social determinants of health? 
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Chronic disease epidemiology has generally conceived risk of disease as residing within 
individuals and in their personal behaviour (Schwartz, Susser, & Susser, 1999) and has therefore 
focused on proximate, individual-level risk factors (McMichael, 1999). The interactions among 
individuals, and between individuals and their social and physical environment, are either 
considered as potential confounders or fall completely outside the scope of most research 
(Schwartz et al., 1999). However, individual-level risk factors do not completely explain social 
gradients in health. For example, in the original White-hall study, a prospective cohort study of 
17,530 male public servants in London, conventional individual-level risk factors for coronary 
artery disease – blood pressure, smoking, cholesterol, BMI and level of physical activity – 
explained only one quarter of the observed social gradient in coronary disease mortality (Marmot, 
Rose, Shipley, & Hamilton, 1978). In recognition of the shortcomings of the traditional approach, 
interest in what has come to be known as ‘social epidemiology’ has grown markedly in recent 
years. 
Social epidemiology is concerned with the social distribution and social determinants of Health and 
illness (Berkman & Kawachi, 2000). According to Krieger (2001), the three main theories invoked to 
explain social inequalities in health are: (1) psychosocial; (2) the social production of disease or the 
‘political economy’ of Health; and (3) ecosocial theory and related multilevel frameworks. 
Psychosocial theories concentrate on endogenous biological responses to human interactions 
(Krieger, 2001). Chronic anxiety, insecurity, low self-esteem, social isolation and lack of control 
over work affect mental and physical health (Brunner & Marmot, 1999). Psychosocial stressors 
might be directly pathogenic (Krieger, 2001), affecting a range of physiological pathways, or they 
might affect health indirectly through stress-induced behaviours such as smoking. The physio-
logical systems mediating biological responses include the autonomic nervous system, the 
hypothalamic– pituitary–adrenal (HPA) axis, and the cardiovascular, metabolic and immune 
systems (McEwen, 1998). Acute stress initiates adaptive, physiological responses involving the 
autonomic nervous system and the HPA axis, the ‘fight or flight’ response, but chronic and/or 
repeated stress might lead to maladaptive, pathological responses (McEwen, 1998). 
The social production of disease theories propose, by contrast, that the fundamental causes of 
social inequalities in health are the actions of the economic and political institutions which create 
and perpetuate economic and social privilege and disadvantage (Krieger, 2001). Health 
inequalities result from the differential accumulation of exposures and experiences which originate 
in material disadvantage (Lynch, Smith, Kaplan, & House, 2000). Health inequalities are rooted in 
the social structure, rather than in individuals’ behaviour or in their inability to manage stress 
(Krieger, 2001). 
An ecosocial theoretical framework integrates biological and social explanations for health 
inequalities by examining how we embody, or incorporate biologically, the material and social 
world in which we live (Krieger, 2001). The pathways linking disadvantage and disease are 
formed both by societal arrangements of power and property, and by the constraints and 
possibilities of our biology (Krieger, 2001). There is a cumulative interplay between exposure, 
susceptibility and resistance, with each factor and its contribution conceptualised at multiple levels 
– individual, community, regional, national and global (Krieger, 2001). Can we use an ecosocial 
framework to understand the ESRD burden in Indigenous populations? What evidence would 
enable us to outline discrete pathways linking disadvantage and biological processes, culminating 
in ESRD in Indigenous Australians? 
 
Pathways, operating at different levels, linking experiences of 
disadvantage with their biological embodiment in ESRD in Indigenous 
Australians 
 
In the following section, we will outline a number of direct and indirect pathways linking disadvantage 
with kidney disease and present the evidence, largely from research amongst Indigenous Australians, to 
support six such pathways: 
1. direct linkage from disadvantage to renal damage; 
2. indirect linkage via psychosocial factors; 
3. indirect and intergenerational linkage via damaging health behaviours; 
4. indirect linkage via factors in the health-care system; 
5. linkage of cultural factors and renal disease; and 
6. linkage of government/corporate policies to renal disease. 
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Direct linkage from disadvantage to renal damage 
 
There is strong evidence linking house crowding, via endemic and epidemic streptococcal skin 
infection, to the incidence of ESRD (Cass et al., 2002b). Living conditions, notably overcrowded 
sleeping arrangements, have been associated with the presence of scabies (Currie & Carapetis, 
2000; Gulati, Singh, & Braganza, 1977; Landwehr, Keita, Ponnighaus, & Tounkara, 1998). 
Scabies and streptococcal skin sores are the most important skin infections in central and northern 
Australia (Currie & Carapetis, 2000). Scabies is endemic in many remote communities, being 
found in up to 50% of children. The cycles of scabies transmission underlie the high prevalence of 
skin sores. Up to 70% of children have skin sores, with group A streptococcus (GAS) being the 
major pathogen (Currie & Carapetis, 2000; Streeton, Hanna, Messer, & Merianos, 1995). 
In a cross-sectional study in a high-risk remote community, the presence of skin sores and 
scabies in both children and adults was associated with albuminuria (Hoy et al., 1998). Adults 
with persistent antibodies to streptococcal M protein, markers of past GAS infection, were far 
more likely than those lacking such antibodies to have albuminuria (Goodfellow et al., 1999). 
GAS is responsible for the continuing outbreaks of acute post-streptococcal glomerulonephritis 
(APSGN) (Atkins, 2001; Currie & Carapetis, 2000; Streeton et al., 1995). A retrospective cohort 
study showed that adults with a documented history (14.6 years earlier on average) of APSGN had 
an adjusted odds ratio of6.1 (95% CI, 2.2–16.9) for albuminuria, compared with adults lacking a 
history of APSGN (White, Hoy, & McCredie, 2001). 
 
Indirect linkage via psychosocial factors 
 
It has been proposed that biological responses to environmental stress could mediate the 
predisposition to poor health outcomes of indigenous populations in industrialised countries 
(Daniel, O’Dea, Rowley, McDermott, & Kelly, 1999). In one study, glycosylated haemoglobin 
concentration, which is elevated by stress-associated catecholamine release, was measured as a 
biomarker of ‘psychogenic stress’. An analysis of the data, controlled for diabetic status, found 
that glycosylated haemoglobin concentration was higher in Indigenous Australians (Daniel et al., 
1999). We have demonstrated a strong association between high unemployment, low educational 
attainment, low income and the incidence of ESRD (Cass et al., 2002b). Unemployment, poor 
education and low income result in a lack of control over one’s life, social isolation and 
alienation, all of which are potent stressors (Berkman & Kawachi, 2000). 
To some extent, the much steeper social gradient in the incidence of ESRD (Cass et al., 2002b) 
might be due to the greater relative disadvantage of Indigenous Australians. However, aspects of 
colonisation and ‘westernisation’, including dispossession and separation from their land, forced 
removal of children from family and kin, racial discrimination and social marginalisation, have 
been recognised as key issues affecting health status (Devitt, Tsey, & Hall, 2001; Wilson, 1997). 
Loss of control by Indigenous Australians over their own lives, their communities and their 
environment has been identified as a potent cause of ill-health (Trudgen, 2000). 
Although a growing body of evidence associates chronic stress and psychosocial factors with a 
range of health outcomes relevant to the initiation and progression of renal disease, including 
hypertension ( Anderson, Myers, Pickering, & Jackson, 1989; Schnall, Schwartz, Landsbergis, 
Warren, & Pickering, 1992), progression of atherosclerosis (Everson et al., 1997) and susceptibility 
to infection (Cohen et al., 1997), research along these lines has not yet been undertaken amongst 
Indigenous Australians.  
 
Indirect and intergenerational linkage via damaging health behaviours 
 
Australians of lower socio-economic status are more likely to smoke, to be overweight and to be 
inactive (National Health Strategy, 1992). Indigenous adults are even more likely to smoke and to 
be obese (Australian Bureau of Statistics and Australian Institute of Health and Welfare, 1999). 
Nationally, approximately 54% of Indigenous Australians smoke, compared with 22% of all 
Australians (Ivers, 2001). Smoking, obesity and lack of exercise are risk factors for diabetes, 
hypertension and hyperlipidaemia. These conditions might both initiate renal damage and facilitate 
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progression of existing renal disease towards ESRD (Muntner, Coresh, Smith, Eckfeldt, & Klag, 
2000; Ruggenenti, Schieppati, & Remuzzi, 2001). 
Smoking is associated with albuminuria and abnormal renal function (Pinto-Sietsma et al., 
2000). It is an established risk factor for ESRD (Klag et al., 1997), and is associated with 
progression of renal disease (Orth et al., 1998; Ritz, Ogata, & Orth, 2000). Both active 
(Celermajer et al., 1993) and passive smoking (Celermajer et al., 1996) have been associated with 
endothelial dysfunction in human studies. Endothelial cell function might be crucial in 
determining whether healing or scarring will result after renal injury (Fogo, 2000). Normally, 
glomerular endothelial cells inhibit cellular processes which lead to scarring. However, in 
response to a variety of stimuli, which might include smoking, glomerular endothelial cells release 
endothelin (Benigni & Remuzzi, 1998) and plasminogen activator-inhibitor-1 (Oikawa, Freeman, 
Lo, Vaughan, & Fogo, 1997). These factors have been linked, in vitro, to hypertrophy of the 
glomeruli, increased cellular matrix and fibrosis – processes which lead to renal scarring (Fogo, 
2000). 
Smoking might also play a role in the intergenerational transfer of risk for ESRD. Among 
indigenous births, maternal smoking is a known cause of IUGR (Sayers & Powers, 1997), which 
might result in lower nephron endowment and a predisposition to ESRD. Maternal malnutrition is 
another known cause of IUGR (Sayers & Powers, 1997). In many remote indigenous communities, 
there is poor access to affordable healthy food (Lee, O’Dea, & Mathews, 1994). Low folate intake 
is prevalent (Lee et al., 1994) and has been associated, in studies in other populations, with LBW 
(Rao et al., 2001; Scholl, Hediger, Schall, Khoo, & Fischer, 1996). 
 
Indirect linkage via factors in the health-care system 
 
Socioeconomic disadvantage, residence in remote communities and racial discrimination are 
associated with limited access to the health care which might otherwise prevent ESRD. For 
example, indigenous women are less likely to attend antenatal care early in their pregnancy and are 
more likely to have two or fewer attendances (Plunkett et al., 1996). This might relate to both 
socio-economic disadvantage (Turrell et al., 1999) and to remoteness from antenatal services 
(Plunkett et al., 1996). Late presentation to antenatal services has been associated with risk of 
LBW (de Costa & Child, 1996). Almost 200 indigenous communities, mostly in central and 
northern Australia, are more than 100 km from the nearest primary health-care facility (Bailie et 
al., 2002). In addition to antenatal services, primary health care provides a range of services which 
could prevent ESRD, such as scabies eradication programs (Wong et al., 2001). 
Remote Indigenous Australians have limited access to secondary prevention programs which 
might otherwise reduce the risk of renal disease progression. There is evidence from numerous 
randomised controlled trials and meta-analyses that strict blood pressure control, particularly 
using ACE inhibitors or angiotensin II receptor blockers, together with rigorous control of 
diabetes, is effective in preventing progression to ESRD (Ruggenenti et al., 2001). In a remote 
community in Northern Australia, a community-based cardiovascular and renal protective 
program was shown to be effective in reducing premature death and progression to ESRD among 
Indigenous adults with early renal disease (Hoy, Baker, Kelly, & Wang, 2000). The program was 
based on (1) the use of ACE inhibitors, combined with other antihypertensives, if needed, to 
achieve blood pressure goals; (2) attempts to improve control of blood glucose and lipid levels; 
and (3) health education. Screening programs in remote communities have consistently found that 
at least 25% of adults have albuminuria (Hoy et al., 1998; McDonald et al., 2002; Rowley et al., 
2000b). Despite this indisputable evidence, there has been no coordinated national approach to 
providing secondary prevention services at a community level. 
There is also clear evidence of poor access to tertiary ESRD treatment services. Forty-eight per 
cent of indigenous ESRD patients starting treatment during 1993–1998 lived in regions without 
ESRD treatment facilities (Cass et al., 2001b). Many needed to travel hundreds of kilometres to 
obtain renal care. By contrast, virtually all non-indigenous patients (99.8%) lived in regions with 
ESRD treatment facilities. Indigenous ESRD patients are more likely to be referred to a 
nephrologist late in the course of their renal disease (Cass, Snelling, Cunningham, Wang, & Hoy, 
2002e). Late referral is associated with increased mortality on ESRD treatment (Cass et al., 
2002a) and is more common in disadvantaged areas (Cass, Cunningham, Snelling, Wang, & Hoy, 
2002c). 
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Indigenous Australian ESRD patients have significantly reduced access to renal transplantation. 
This is not explained by differences in age, sex, co-morbidities or cause of renal disease (Cass, 
Cunningham, Snelling,  Wang, & Hoy, 2001a). This finding is consistent with US research focused 
on African Americans’ access to transplantation, which suggests that disparities in access are not 
accounted for by differences in medical suitability or patient preferences (Ayanian, Cleary, 
Weissman, & Epstein, 1999; Epstein et al., 2000). It is also consistent with recent research 
indicating a disparity in the use of diagnostic and therapeutic procedures for indigenous and non-
indigenous patients in Australian public hospitals. This suggests that there might be systematic 
differences in the treatment of indigenous patients (Cunningham, 2002). Further re-search is 
required to explore the contribution of racial discrimination, whether overt or covert, to reduced 
access to ESRD treatment. 
 
Linkage of cultural factors and renal disease 
 
Cultural differences affect Indigenous Australians’ access to, and utilisation of, health services. 
It has been suggested that a grossly deficient standard of cross-cultural communication has been 
accepted as the norm in some settings (Devitt & McMasters, 1998). Patients’ poor understanding 
of their own chronic renal disease has been linked to non-compliance and reduced active 
involvement in their own management (Devitt & McMasters, 1998). In a recent qualitative study 
investigating the effectiveness of communication in ESRD care for Indigenous Australians, a 
picture emerged of pervasive miscommunication, often unrecognised by both the patients and their 
health carers (Cass et al., 2002d). A shared understanding of fundamental issues concerning 
prevention, diagnosis and treatment was rarely achieved. Other research has suggested that the 
communication gap might be so wide, and so ingrained in health care, that it is not even perceived 
by staff (Trudgen, 2000). Effective communication has been shown to correlate with improved 
outcomes, including physiological criteria such as adequacy of blood pressure and blood sugar 
control (Stewart, 1995). Therefore, ineffective communication is likely to impede attempts to 
retard the progression of renal damage to ESRD. 
 
Linkage of government/corporate policies to renal disease 
 
Australian governments have attempted to address the social disadvantage of Indigenous 
Australians, but with limited success. Large-scale infrastructure development has occurred in 
some communities, with projects designed to ensure adequate water supply, sanitation, housing 
and drainage (Bailie & Runcie, 2001). However, a recent survey of houses funded by the 
Indigenous Housing Authority of the Northern Territory showed that 62% of houses did not meet 
the required standards for the storage and preparation of food, and that, in 45% of houses, bath and 
toilet facilities were not functional (Bailie & Runcie, 2001). A recent review of education 
strategies revealed deteriorating outcomes, with an overall decline in school attendance and very 
low proportions of students achieving national reading benchmarks in primary school (Collins, 
1999). We have discussed above the linkage between both housing conditions and educational 
outcomes and the development of ESRD. 
Corporate policies might also be playing an adverse role. As noted above, the prevalence of 
tobacco use is much higher among Indigenous Australians. There is evidence of tobacco 
advertising campaigns specifically targeting this group (Ivers, 2001). The promotion, in some 
indigenous communities, of particular cigarette brands, with the distribution of ‘giveaway’ 
products, such as T-shirts, has been reported, and tobacco companies are prominent in the 
sponsorship of remote community sporting events. This is consistent with the aggressive 
marketing tactics used to target indigenous populations of other South Pacific nations (Ivers, 
2001). We have discussed above the various pathways linking tobacco use with the initiation and 
progression of renal disease. 
We have outlined six discrete pathways linking disadvantage and kidney disease. Others are 
likely to exist. It is clear that an ecosocial multilevel framework is both appropriate and useful in 
understanding ESRD among Indigenous Australians. How might this under-standing lead to an 
evidence-based approach to the prevention of ESRD? 
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A life-course approach to the prevention of ESRD 
 
Nephrologists understand ESRD from a traditional, biomedical perspective, in which ESRD is 
attributed to one of a range of discrete primary disease processes. This view is inconsistent with 
the pathophysiological model which we have proposed. A limited biomedical perspective cannot 
explain the striking social gradient in the incidence of ESRD in Indigenous Australians. The 
explanation put forward in this paper enables us to bring together an understanding of the social, 
cultural and environmental determinants of Health with an under-standing of the biology of renal 
disease. A better understanding of the discrete pathways linking disadvantage and the associated 
discrimination with their biological embodiment across the life-course (Krieger, 2001), enables us 
to identify targeted prevention programs to address this excess burden of renal disease. 
Individual-level interventions alone, using pharmacological and lifestyle interventions for people 
at high risk, are necessary but not sufficient to address the many determinants operating at the 
individual, community, regional and national levels. Despite the relative lack of evidence for 
efficacy of primary prevention to prevent indigenous ESRD, there is evidence that community-
based intervention, in partnership with indigenous communities, can mitigate the early stages in 
the pathophysiological pathway to ESRD. 
Primary preventive initiatives must address the period from before conception to the 
development of albuminuria. Such initiatives should include: 
 
 improved access to antenatal services to reduce the prevalence of IUGR; 
 community initiatives such as the Strong Women, Strong Babies, Strong Culture Program 
which resulted in improvement in birth weights in pilot communities (Mackerras, 1998); 
 screening and intensive management of diabetes in pregnancy (Dabelea & Pettitt, 2001) and 
encouragement of breastfeeding, especially for the children of mothers who had diabetes 
during pregnancy (Pettitt, Forman, Hanson, Knowler, & Bennett, 1997) to prevent the 
development of obesity and early onset of type 2 diabetes; 
 prevention of obesity in early childhood, particularly due to ‘catch up growth’ in those with 
LBW, as they are at greatest risk of developing diabetes (Yajnik, 2002) and renal disease 
(Hoy et al., 1999); 
 early childhood development initiatives to improve educational achievement and life-skills; 
 increased participation in primary, secondary and tertiary education (Bauert, Brown, 
Collins, & Martin, 2001); 
 training community members to improve housing infrastructure and to maintain 
improvements (Pholeros, Rainow, & Torzillo, 1994), thus also providing employment 
opportunities; 
 food supply initiatives to improve access to affordable healthy food (Lee, Bonson, Yarmirr, 
O’Dea, & Mathews, 1995; Rowley et al., 2000a); 
 community-based scabies control programs; 
 culturally appropriate healthy nutrition, physical activity and quit smoking programs and 
legislative initiatives to regulate tobacco advertising; and 
 intensive nutrition and physical activity programs to delay or prevent the onset of diabetes 
in people with IGT (Knowler et al., 2002; Tuomilehto et al., 2001). 
 
Secondary prevention, covering the period from the development of albuminuria to ESRD, will 
require a coordinated, national program to provide community-based screening and intervention for 
hypertension, diabetes and albuminuria. Strict control of blood pressure with ACE inhibitors as first-
line therapy, and of diabetes with oral hypoglycaemics and insulin, has been demonstrated to be 
effective in preventing progression to ESRD (Hoy et al., 2000). Accumulating evidence, albeit not 
among Indigenous Australians, suggests that smoking cessation and lipid lowering (Fried, Orchard, & 
Kasiske, 2001) might also be effective strategies. Improved, early access to nephrological 
services might prevent progression to ESRD, and should, with appropriate ESRD treatment, 
improve outcomes (Cass et al., 2002a). 
Tertiary prevention initiatives, designed to improve access to renal transplantation and to 
improve communication between health-care providers and Indigenous ESRD patients, are 
required to improve ESRD treatment outcomes. However, an emphasis on primary and 
secondary prevention would result in improvements in health above and beyond the prevention 
or amelioration of ESRD. 
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Our hypothesis of the causation of ESRD among Indigenous Australians is likely to be 
relevant to an understanding of patterns of renal disease in other high-risk populations, 
particularly indigenous people in the developed world and the people in developing countries. 
Furthermore, analogous pathways might be relevant to other chronic diseases, such as diabetes 
and cardiovascular disease. If we are able to confirm the various pathways from disadvantage to 
human biology, we will be better placed to advocate evidence-based prevention strategies, both 
within and beyond the scope of the health-care system. Although there might be a compel-ling 
case now for building dialysis units in indigenous communities, we could provide a better long-
term answer to the call for help made by the people of Kintore and Kiwirrkura. 
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